EvangeliaKatsoulakisMD

Radiation Oncology • Tampa, FL

Physician

Join to view full profile

Dr. Katsoulakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Katsoulakis' full profile

Already have an account?

Office
2 Tampa General Cir
Fl 3
Tampa, FL 33606
Phone+1 813-844-7585

Education & Training

Maimonides Medical Center/SUNY Downstate HSUResidency, Radiation Oncology, 2028 - 2032
State University of New York Downstate Medical Center College of MedicineClass of 2028
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology
Rutgers Health/New Jersey Medical SchoolInternship, Internal Medicine

Certifications & Licensure

CT State Medical License Current
FL State Medical License Active through 2026
CA State Medical License Active through 2025
NJ State Medical License Active through 2025
NY State Medical License Active through 2025
American Board of Preventive Medicine Clinical Informatics
American Board of Radiology Radiation Oncology

Clinical Trials

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2011 Feb 01
Completed
Phase 2
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
Recruiting
Phase 2, Phase 3
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA Start of enrollment: 2014 Apr 21
Active, not recruiting
Phase 2, Phase 3
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2014 Oct 27
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

16 citations
Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer
Nadeem Riaz, Jeremy Setton, Moses Tam, Eric J. Sherman, Felix Ho
Oral Oncology. 2014-09-01
93 citations
Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
Wei Mu, Lei Jiang, Yu Shi, Ilke Tunali, Jhanelle E. Gray
Journal for Immunotherapy of Cancer. 2021-06-01
52 citations
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Kosj Yamoah, Kyung Min Lee, Shivanshu Awasthi, Patrick R Alba, Cristina Perez
JAMA Network Open. 2022-01-04

Journal Articles

Pharmacogenomics and breast cancer.
Lymberis SC, Parhar PK, Katsoulakis E, Formenti SC., Pharmacogenomics, 1/20/2014
Computerized tomography-based radiotherapy improves heterotopic ossification outcomes.
Mourad WF, Packianathan S, Ma JK, Yang CC, Shourbaji RA, He R, Zhang Z, Kanakamedala MR, Khan MA, Mobit P, Katsoulakis E, Nabhani T, Jennelle R, Russell GV, Vijayakuma..., Bone, 11/8/2013
Temporary organ displacement coupled with image-guided, intensity-modulated radiotherapy for paraspinal tumors.
Katsoulakis E, Solomon SB, Maybody M, Housman D, Niyazov G, Riaz N, Lovelock M, Spratt DE, Erinjeri JP, Thornton RH, Yamada Y., Radiat Oncol, 6/24/2013
Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation.
9. Tam M, Riaz R, Salgado LR, Spratt DE, Katsoulakis E, Ho A, Morris LG, Wong R, Wolden S, Rao S, Lee N., Journal of Radiation Oncology, 3/12/2013
Image-guided Radiation Therapy for Liver Tumors: Gastrointestinal Histology Matters.
Katsoulakis E, Riaz N, Cannon DM, Goodman K, Spratt DE, Lovelock M, Yamada Y., Am J Clin Oncol, 3/4/2013
Image guidance in malignant gliomas: a focused strategy.
12. Katsoulakis E, Beal K, Yamada Y., CNS Oncology, 8/15/2012
Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection.
Schreiber D, Rineer J, Katsoulakis E, Sroufe RL, Lange CS, Nwokedi E, Schwartz D, Choi K, Rotman M., Am J Clin Oncol, 2/10/2012
Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS, Duan H, Katsoulakis E, Salame G, Lee YC, Abulafia O., Int J Gynecol Cancer, 8/21/2011
Survival following sublobar resection for early-stage non-small cell lung cancer with or without adjuvant external beam radiation therapy: a population-based study.
Rineer J, Schreiber D, Katsoulakis E, Nabhani T, Han P, Lange C, Choi K, Rotman M., Chest., 2/17/2010
Genome-wide dynamic transcriptional profiling of the light-to-dark transition in Synechocystis sp. strain PCC 6803.
Gill RT, Katsoulakis E, Schmitt W, Taroncher-Oldenburg G, Misra J, Stephanopoulos G., J Bacteriol, 7/18/2002
Join now to see all

Books/Book Chapters

Hypofractionation: Scientific Concepts and Clinical Experiences.
Chapter: The Impact of Dose on Spine Radiosurgery
Page 95 - 113Katsoulakis E, Cox B, Bilsky M, Yamada YEditors: Pollack A, Ahmed M..LumiText Publishing, FloridaEdition 1,2011

Lectures